BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 2480904)

  • 1. Regulation of the human alternative complement pathway: formation of a ternary complex between factor H, surface-bound C3b and chemical groups on nonactivating surfaces.
    Carreno MP; Labarre D; Maillet F; Jozefowicz M; Kazatchkine MD
    Eur J Immunol; 1989 Nov; 19(11):2145-50. PubMed ID: 2480904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H.
    Meri S; Pangburn MK
    Proc Natl Acad Sci U S A; 1990 May; 87(10):3982-6. PubMed ID: 1692629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.
    Kazatchkine MD; Fearon DT; Silbert JE; Austen KF
    J Exp Med; 1979 Nov; 150(5):1202-15. PubMed ID: 501288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system.
    Brown EJ; Joiner KA; Gaither TA; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):409-15. PubMed ID: 6223077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species specificity of recognition by the alternative pathway of complement.
    Horstmann RD; Pangburn MK; Müller-Eberhard HJ
    J Immunol; 1985 Feb; 134(2):1101-4. PubMed ID: 3155536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanism of activation of the alternative complement pathway by the classical pathway: protection of C3b from inactivation by covalent attachment to C4b.
    Meri S; Pangburn MK
    Eur J Immunol; 1990 Dec; 20(12):2555-61. PubMed ID: 2148521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b.
    Mold C; Kingzette M; Gewurz H
    J Immunol; 1984 Aug; 133(2):882-5. PubMed ID: 6234363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the mechanism of recognition in the complement alternative pathway using C3b-bound low molecular weight polysaccharides.
    Pangburn MK
    J Immunol; 1989 Apr; 142(8):2759-65. PubMed ID: 2467938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H.
    Horstmann RD; Sievertsen HJ; Knobloch J; Fischetti VA
    Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1657-61. PubMed ID: 2964038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C3b generation is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from salmonellae.
    Jimenez-Lucho VE; Joiner KA; Foulds J; Frank MM; Leive L
    J Immunol; 1987 Aug; 139(4):1253-9. PubMed ID: 2440949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface.
    Pangburn MK; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1983 Oct; 131(4):1930-5. PubMed ID: 6225800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
    Fearon DT
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5867-71. PubMed ID: 293688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential inactivation of the C5 convertase of the alternative complement pathway by factor I and membrane cofactor protein (MCP).
    Seya T; Okada M; Matsumoto M; Hong KS; Kinoshita T; Atkinson JP
    Mol Immunol; 1991 Oct; 28(10):1137-47. PubMed ID: 1833639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of complement-protein-C3b density on the binding of complement factor H to surface-bound C3b.
    Koistinen V
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):255-9. PubMed ID: 1835839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the alternative pathway of human complement by C1q.
    Fishelson Z; Müller-Eberhard HJ
    Mol Immunol; 1987 Sep; 24(9):987-93. PubMed ID: 2958692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B.
    Joiner K; Sher A; Gaither T; Hammer C
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6593-7. PubMed ID: 2944112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.
    Fishelson Z; Müller-Eberhard HJ
    J Immunol; 1984 Mar; 132(3):1425-9. PubMed ID: 6229580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of recognition in the alternative pathway of complement. Effect of polysaccharide size.
    Pangburn MK
    J Immunol; 1989 Apr; 142(8):2766-70. PubMed ID: 2467939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases.
    Pangburn MK
    J Immunol; 1986 Mar; 136(6):2216-21. PubMed ID: 2419425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of resistance to lysis by the alternative complement pathway in Trypanosoma cruzi trypomastigotes: effect of specific monoclonal antibody.
    Schenkman S; Güther ML; Yoshida N
    J Immunol; 1986 Sep; 137(5):1623-8. PubMed ID: 2943798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.